Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

(2021) Chaolin Huang et al.   LANCET

Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial

(2021) Jordana B Cohen et al.   Lancet Respiratory Medicine

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

(2021) Emma C. Thomson et al.   CELL

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

(2021) Pengfei Wang et al.   NATURE

Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soup

(2021) Eric J. Rubin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

(2021)   NEW ENGLAND JOURNAL OF MEDICINE

Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19

(2021) Aakriti Gupta et al.   Nature Communications

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

(2021) Obbina Abani et al.   LANCET

Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma

(2021) Sandile Cele et al.   NATURE

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hemodynamic Impact of Cardiovascular Antihypertensive Medications in Patients With Sepsis-Related Acute Circulatory Failure

(2020) Charles de Roquetaillade et al.   SHOCK

Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients

(2020) David M. Smadja et al.   ANGIOGENESIS

Coagulopathy of Coronavirus Disease 2019

(2020) Toshiaki Iba et al.   CRITICAL CARE MEDICINE

Optimizing the Trade-off Between Learning and Doing in a Pandemic

(2020) Derek C. Angus   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Treating COVID-19—Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics

(2020) Andre C. Kalil   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

Virological assessment of hospitalized patients with COVID-2019

(2020) Roman Wölfel et al.   NATURE

Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection

(2020) David S. Fedson et al.   mBio

Meta-analysis of Effectiveness of Statins in Patients with Severe COVID-19

(2020) Chia Siang Kow et al.   AMERICAN JOURNAL OF CARDIOLOGY

Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science

(2020) Paul C Evans et al.   CARDIOVASCULAR RESEARCH

In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19

(2020) Xiao-Jing Zhang et al.   Cell Metabolism

Emerging pharmacological therapies for ARDS: COVID-19 and beyond

(2020) Shahd Horie et al.   INTENSIVE CARE MEDICINE

A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19

(2020) Ying-feng Lu et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Continued in-hospital ACE inhibitor and ARB Use in hypertensive COVID-19 patients is associated with positive clinical outcomes

(2020) Katherine W Lam et al.   JOURNAL OF INFECTIOUS DISEASES

Randomized Trials Versus Common Sense and Clinical Observation

(2020) Alexander C. Fanaroff et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents

(2020) Anton De Spiegeleer et al.   Journal of the American Medical Directors Association

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

(2020) Laura Riva et al.   NATURE

Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications

(2020) Joan T. Merrill et al.   Nature Reviews Rheumatology

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

Management of epigenomic networks entailed in coronavirus infections and COVID-19

(2020) Ranim El Baba et al.   Clinical Epigenetics

Relation of Statin Use Prior to Admission to Severity and Recovery Among COVID-19 Inpatients

(2020) Lori B. Daniels et al.   AMERICAN JOURNAL OF CARDIOLOGY

Statin Treatment of COVID-19

(2020) David S. Fedson   AMERICAN JOURNAL OF CARDIOLOGY

Microvascular dysfunction in COVID-19: the MYSTIC study

(2020) Alexandros Rovas et al.   ANGIOGENESIS

Endothelial dysfunction in COVID-19: Current findings and therapeutic implications

(2020) Matthias P. Nägele et al.   ATHEROSCLEROSIS

Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19

(2020) Lucas C. Godoy et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

COVID-19 is, in the end, an endothelial disease

(2020) Peter Libby et al.   EUROPEAN HEART JOURNAL

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19

(2020) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis

(2020) Panagiotis Skendros et al.   JOURNAL OF CLINICAL INVESTIGATION

Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies

(2020) Ting Zhou et al.   JOURNAL OF EXPERIMENTAL MEDICINE

SARS-CoV-2 detection, viral load and infectivity over the course of an infection

(2020) Kieran A. Walsh et al.   JOURNAL OF INFECTION

Drug repurposing approach to fight COVID-19

(2020) Thakur Uttam Singh et al.   Pharmacological Reports

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms

(2020) David E. Gordon et al.   SCIENCE

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

(2020) Paul Bastard et al.   SCIENCE

Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines

(2020) SangJoon Lee et al.   TRENDS IN IMMUNOLOGY

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

(2020) Olivier Hermine et al.   JAMA Internal Medicine

Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia

(2020) Carlo Salvarani et al.   JAMA Internal Medicine

Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study

(2020) Giacomo Grasselli et al.   Lancet Respiratory Medicine

Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19

(2020) Minako Yamaoka-Tojo   Biomedical Journal

Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies

(2020) André J. Scheen   DIABETES & METABOLISM

COVID-19, host response treatment, and the need for political leadership

(2020) David S. Fedson   JOURNAL OF PUBLIC HEALTH POLICY

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

(2020) Ventura A. Simonovich et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties

(2020) Michael A Matthay et al.   Lancet Respiratory Medicine

Association of Statin Use With the In-Hospital Outcomes of 2019-Coronavirus Disease Patients: A Retrospective Study

(2020) Yongzhen Fan et al.   Frontiers in Medicine

Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19

(2020) Ning Rosenthal et al.   JAMA Network Open

Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis

(2020) Anubodh S. Varshney et al.   AMERICAN HEART JOURNAL

Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation

(2019) Isabella Viana Gomes Silva et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Propensity-score matching with competing risks in survival analysis

(2018) Peter C. Austin et al.   STATISTICS IN MEDICINE

Clinician-initiated research on treating the host response to pandemic influenza

(2017) David S. Fedson   Human Vaccines & Immunotherapeutics

Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events

(2017) Kwang Kon Koh et al.   Korean Circulation Journal

Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis

(2017) Setor K Kunutsor et al.   Lancet Haematology

Treating Ebola patients: a ‘bottom up’ approach using generic statins and angiotensin receptor blockers

(2015) David S. Fedson et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

A Multicenter Randomized Trial of Atorvastatin Therapy in Intensive Care Patients with Severe Sepsis

(2013) Peter Kruger et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Treating influenza with statins and other immunomodulatory agents

(2013) David S. Fedson   ANTIVIRAL RESEARCH

Matching Methods for Causal Inference: A Review and a Look Forward

(2010) Elizabeth A. Stuart   STATISTICAL SCIENCE

Competing Risk Regression Models for Epidemiologic Data

(2009) B. Lau et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY